Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
YoungHeartValve is a Polymeric Hyaluronan-Enhanced Transcatheter Aortic Valves which were developed by engineers by inspiration from nature.
Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.
RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.
Juniper Biomedical is a neuromodulation MedTech company that is dramatically improving therapy for patients with pelvic health conditions.
Chosen Diagnostics is to improve health care delivery for patients by personalizing their medicine.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
Pip Care provides a personalized surgical journey platform, optimizing perioperative care processes and supporting patients and care teams.
Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
Soterix Medical develops devices and accessories based on neuromodulation and brain stimulation technologies.
Regenerative Medical Solutions is a biotechnology company developing regenerative medical products used to treat diabetes.
CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.
Homecare Hub is an platform which has developed a marketplace that helps patients to find the high quality home care providers.
MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.
BrainCheck is a digital platform for cognitive assessment and care that evaluates brain health across clinical and non-clinical settings.
Versiti provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related diseases.
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
GreenMark is a healthcare company providing health-based benefits using nanoparticles.
Rendever is a research-based virtual reality platform that provides cognitive stimulation, socialization, and therapy for older adults.
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Pharmaceutical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Perspective Therapeutics received $175.0M in a Post Ipo Equity round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include YoungHeartValve, Codagenix, RIVANNA, Juniper Biomedical, Chosen Diagnostics. These companies were founded in 2020 or later.